US Patent 11214607 Glucagon-receptor selective polypeptides and methods of use thereof
Patent 11214607 was granted and assigned to Intarcia Therapeutics, Inc. on January, 2022 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 11214607 Glucagon-receptor selective polypeptides and methods of use thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
